KlausTGottliebMDPhD
Gastroenterology • Santa Maria, CABiliary Tract Disease, Inflammatory Bowel Disease, Pancreas Disease
Klaus Gottlieb, MD
Dr. Gottlieb is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1315 South Miller St.
Ste 101
Santa Maria, CA 93454Phone+1 805-349-2945Fax+1 805-349-2887- Is this information wrong?
Summary
- Dr. Klaus Gottlieb is a translational scientist in immunology drug development with American Board certifications in Internal Medicine and Gastroenterology. He holds an MD-PhD (Dr.med.) degree from Bonn University in Germany, an MBA from Indiana University, and a Master of Science in Biotechnology from Johns Hopkins.He was most recently employed at the FDA, Quintiles (IQVIA), and Synthetic Biologics, Inc. He is now a Medical Fellow with Eli Lilly and Company and practices gastroenterology part-time in Santa Maria, CA.
Education & Training
Johns Hopkins UniversityMS, Biotechnology, 2009 - 2012
Indiana University School of MedicineFellowship, Gastroenterology, 1993 - 1995
Loyola University Medical CenterFellowship, Gastroenterology, 1991 - 1993- Loyola University Medical CenterResidency, Internal Medicine, 1988 - 1991
University of Bonn Faculty of MedicineClass of 1987
Certifications & Licensure
CA State Medical License 2016 - 2026
WA State Medical License 1998 - 2024
IL State Medical License 1989 - 1993- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Fellow (FASGE) American Society for Gastrointestinal Endoscopy
- Fellow (FACP) American College of Physicians, 1995
- Fellow (FACG) American College of Gastroenterology
Clinical Trials
- A Study to Evaluate the Effect of SYN-004 on the PK of IV Ceftriaxone in Adults With a Functioning Ileostomy Start of enrollment: 2015 Mar 01
- A Study of the Effect of SYN-010 on Subjects With IBS-C Start of enrollment: 2015 Jun 01
- A Study of SYN-004 for the Prevention of C.Diff in Patients With a LRTI Start of enrollment: 2015 Oct 01
Publications & Presentations
PubMed
- 1 citationsCan artificial intelligence replace endoscopists when assessing mucosal healing in ulcerative colitis? A systematic review and diagnostic test accuracy meta-analysis.Alessandro Rimondi, Klaus Gottlieb, Edward J Despott, Marietta Iacucci, Alberto Murino, Gian Eugenio Tontini> ;Digestive and Liver Disease. 2023 Dec 5
- 1 citationsPathologist-trained machine learning classifiers developed to quantitate celiac disease features differentiate endoscopic biopsies according to modified marsh score an...Aaron M Gruver, Haiyan Lu, Xiaoxian Zhao, Angie D Fulford, Michael D Soper, Darryl Ballard, Jeffrey C Hanson, Andrew E Schade, Eric D Hsi, Klaus Gottlieb, Kelly M Cred...> ;Diagnostic Pathology. 2023 Nov 11
- Identifying Measures of Suboptimal Healthcare Interaction (SOHI) to Develop a Claims-Based Model for Predicting Patients with Inflammatory Bowel Disease at Risk for SOHI.Stephanie Korrer, April N Naegeli, Lida Etemad, Gabriel Johnson, Klaus T Gottlieb> ;Drugs - Real World Outcomes. 2023 Sep 1
- Join now to see all
Press Mentions
Synthetic Biologics Expands Clinical & Regulatory Leadership Team with Addition of Klaus Gottlieb, MD, FACGJune 2nd, 2015
Promising Celiac Disease Therapies on the HorizonMarch 9th, 2015
Professional Memberships
- Member
- American Institute of Ultrasound in Medicine - AIUMMember
Other Languages
- Spanish, German
Hospital Affiliations
Marian Regional Medical CenterSanta Maria, California
External Links
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
